Ryman Healthcare Limited (NZE:RYM)
New Zealand · Delayed Price · Currency is NZD 2.270
+0.010 (0.44%)
Jun 2, 2026, 11:38 AM NZST
Ryman Healthcare Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -171.35 | -513.75 | -169.67 | 257.84 | 692.87 |
Depreciation & Amortization | 42.55 | 48.46 | 35.37 | 25.97 | 30.59 |
Other Amortization | - | - | 10.62 | 11.74 | 5.11 |
Asset Writedown & Restructuring Costs | 100.66 | 85.87 | 135.63 | -420.47 | -745.89 |
Stock-Based Compensation | 0.74 | 2.43 | 2.93 | - | - |
Other Operating Activities | -19.01 | 214.04 | -116.75 | 103.22 | 33.28 |
Change in Accounts Receivable | -0.07 | -5.6 | -21.98 | -46.55 | -129.02 |
Change in Inventory | - | 2.37 | 2.94 | 11.63 | 0.39 |
Change in Accounts Payable | -11.16 | 7.68 | -2.03 | 41.11 | 9.17 |
Change in Unearned Revenue | - | - | 41.59 | 18.02 | 9.44 |
Change in Other Net Operating Assets | 391.6 | 568.74 | 676.61 | 639.43 | 680.03 |
Operating Cash Flow | 333.97 | 410.25 | 595.26 | 641.95 | 585.98 |
Operating Cash Flow Growth | -18.59% | -31.08% | -7.27% | 9.55% | 41.84% |
Capital Expenditures | -52.09 | -137.87 | -201.82 | -422.94 | -334.29 |
Sale of Property, Plant & Equipment | 2.23 | 0.65 | - | 19.65 | - |
Sale (Purchase) of Intangibles | -0.25 | -3.11 | -6.72 | -20.11 | -14.35 |
Sale (Purchase) of Real Estate | -97.86 | -387.83 | -575.41 | -608.78 | -434.4 |
Other Investing Activities | 0.36 | 2.58 | 5.12 | 1.2 | -4.28 |
Investing Cash Flow | -147.62 | -525.58 | -778.83 | -1,031 | -787.31 |
Long-Term Debt Issued | - | - | 201.22 | 436.72 | 326.92 |
Long-Term Debt Repaid | -195.35 | -885.45 | -3.37 | -752.12 | -2.66 |
Net Debt Issued (Repaid) | -195.35 | -885.45 | 197.85 | -315.4 | 324.26 |
Issuance of Common Stock | 0.85 | 976.52 | - | 2.64 | - |
Repurchase of Common Stock | - | - | - | - | -2.79 |
Common Dividends Paid | - | - | - | -68.09 | -112 |
Other Financing Activities | - | - | -0.35 | 769.44 | - |
Financing Cash Flow | -194.5 | 91.06 | 197.5 | 388.6 | 209.47 |
Foreign Exchange Rate Adjustments | 0.19 | 0.12 | - | - | - |
Net Cash Flow | -7.96 | -24.15 | 13.93 | -0.43 | 8.14 |
Free Cash Flow | 281.88 | 272.38 | 393.44 | 219.01 | 251.68 |
Free Cash Flow Growth | 3.49% | -30.77% | 79.64% | -12.98% | 60.80% |
Free Cash Flow Margin | 32.99% | 35.88% | 57.22% | 37.66% | 49.47% |
Free Cash Flow Per Share | 0.28 | 0.38 | 0.57 | 0.42 | 0.50 |
Cash Interest Paid | 85.85 | 127.1 | 36.79 | 46.86 | 29.24 |
Levered Free Cash Flow | -96.85 | -5,377 | 318.02 | 3,883 | -120.36 |
Unlevered Free Cash Flow | -19.53 | -5,287 | 361.18 | 3,881 | -101.2 |
Change in Working Capital | 380.37 | 573.19 | 697.13 | 663.64 | 570.01 |